GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs.
about
GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposinThe protein interacting with C-kinase (PICK1) interacts with and attenuates parkin-associated endothelial-like (PAEL) receptor-mediated cell deathInternational Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsDrug Discovery Opportunities at the Endothelin B Receptor-Related Orphan G Protein-Coupled Receptors, GPR37 and GPR37L1Regulation of dopamine transporter activity by carboxypeptidase EThe roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC-12 cellsPrecocious cerebellum development and improved motor functions in mice lacking the astrocyte cilium-, patched 1-associated Gpr37l1 receptorThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsAlterations in adult behavioral responses to cocaine and dopamine transporters following juvenile exposure to methamphetamineA Physical Interaction between the Dopamine Transporter and DJ-1 Facilitates Increased Dopamine ReuptakeHunting for the function of orphan GPCRs - beyond the search for the endogenous ligand.Monoamine transporters: vulnerable and vital doorkeepers.Mutation in Parkinson disease-associated, G-protein-coupled receptor 37 (GPR37/PaelR) is related to autism spectrum disorder.Inhibition of Activity of GABA Transporter GAT1 by δ-Opioid Receptor.The role of the ubiquitin proteasome system in synapse remodeling and neurodegenerative diseases.Trafficking of dopamine transporters in psychostimulant actions.Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala.Ex vivo identification of protein-protein interactions involving the dopamine transporter.Synaptic dysfunction in genetic models of Parkinson's disease: a role for autophagy?Control of striatal signaling by g protein regulators.Identification of transcripts with short stuORFs as targets for DENR•MCTS1-dependent translation in human cells.Astroglia as a cellular target for neuroprotection and treatment of neuro-psychiatric disorders.Drug discovery for remyelination and treatment of MS.Interactions of Cathinone NPS with Human Transporters and Receptors in Transfected Cells.GPR37 surface expression enhancement via N-terminal truncation or protein-protein interactionsThe Parkinson's disease-associated GPR37 receptor interacts with striatal adenosine A2A receptor controlling its cell surface expression and function in vivo.Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity.The role of parkinson's disease-associated receptor GPR37 in the hippocampus: functional interplay with the adenosinergic system.Mice lacking the Parkinson's related GPR37/PAEL receptor show non-motor behavioral phenotypes: age and gender effect.CASPR2 forms a complex with GPR37 via MUPP1 but not with GPR37(R558Q), an autism spectrum disorder-related mutation.GPR37L1 modulates seizure susceptibility: Evidence from mouse studies and analyses of a human GPR37L1 variant.Mice lacking Gpr37 exhibit decreased expression of the myelin-associated glycoprotein MAG and increased susceptibility to demyelination.GPCR Retreat 2012: timing is everything.Parkinson's disease-associated receptor GPR37 is an ER chaperone for LRP6.Genome-wide analysis of familial dysautonomia and kinetin target genes with patient olfactory ecto-mesenchymal stem cells.GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain
P2860
Q24293450-4FA92452-67D9-4650-AE0E-9C594B9F48A5Q24295004-D7C920C5-D6C8-4B30-BA95-AA265214A345Q24605072-02D3F427-BE87-43CE-AA73-F5313E4DAD57Q26774799-F9849AE7-689E-4E1A-AD98-998903158AC3Q28570586-B80A5B03-98F0-45B9-A252-6A1F68906A04Q28571211-E9451484-8198-4830-BF7C-F8AC24407E10Q28590565-CC997EE0-08D0-4AC3-9A5E-03125769ECC6Q30486707-8B9BE854-7F50-4518-BA1C-3B87F30D0412Q34311343-2B14DEA3-5136-4DCC-8552-FA42C4D0CE4CQ35754644-BC80DF1F-AE8B-4344-8C4D-87310C18B7D7Q35846184-EDB99B6A-D96F-43DE-A11F-CDA78364B9C5Q35877150-D8CA291F-1204-43B3-A12B-D3059B67B1C2Q36463165-EEC4CCD3-B635-4AB4-A3B4-C101F8B1A794Q36528515-C79B8B17-77C7-4D64-8DF9-F068CD676F61Q37304018-9599F6B0-2002-4A4C-939C-2EF586FFAAB7Q37533305-E78F358C-CB43-4206-BA87-6C614A454102Q37661363-2B71CD50-2DDE-432F-BFBA-1D91E24564D0Q37680542-D4D5C995-9D47-4AE7-A14E-1705B47B1D9AQ37802464-9533F117-FED9-4050-B67B-F4DD0CB643DEQ37919731-30512EEE-6454-4432-89FA-FB3313E93399Q38670029-EF66ADDB-FD8A-4F9B-8EA8-EC44271B0B0EQ39181656-25196EB5-6AB9-442B-B034-D5910FB18EC3Q39375830-C4E6AC04-F68B-4D9E-949A-766DFC4C0198Q39703486-4263FF69-9413-4951-8DA6-2249454DE604Q39792376-18E4297D-B2ED-4150-8574-9FA9F34415D4Q41534391-E175469A-AF9D-4615-89C8-9768D91C46B0Q41954719-ED0F2D5C-BBA9-4F50-AE09-1A46210A76DDQ42927984-A0C427A4-3827-405A-8C2C-A1C65A4FD7DBQ47723787-1F97D814-DCFB-4C7A-AAB7-0F808DAE66E7Q48031082-A6618C86-A7A2-4006-B4E5-442538775C3DQ48176109-781E0BAE-4524-49F7-AEF6-073BE0DB807AQ48205045-1E94FB87-61B9-42B4-8C9D-B844332D52A8Q48228228-CB3B7B1C-76E5-43C3-96F7-C8320AEC6629Q48284862-DE33E96F-77F7-424F-A0C2-D983DE53CDB1Q48363496-1A7B5C31-9CD6-4A9F-A514-C60141DF0C77Q54332876-2890A5C9-199E-4FF1-8130-BA53EB313709Q57990320-0F03DEDD-7D1C-44C2-A5FF-80CA1A0E4B56
P2860
GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
GPR37 associates with the dopa ...... sponses to dopaminergic drugs.
@ast
GPR37 associates with the dopa ...... sponses to dopaminergic drugs.
@en
type
label
GPR37 associates with the dopa ...... sponses to dopaminergic drugs.
@ast
GPR37 associates with the dopa ...... sponses to dopaminergic drugs.
@en
prefLabel
GPR37 associates with the dopa ...... sponses to dopaminergic drugs.
@ast
GPR37 associates with the dopa ...... sponses to dopaminergic drugs.
@en
P2860
P50
P356
P1476
GPR37 associates with the dopa ...... esponses to dopaminergic drugs
@en
P2093
Elisabetta Golini
Glauco P Tocchini-Valentini
P2860
P304
P356
10.1073/PNAS.0703368104
P407
P577
2007-05-22T00:00:00Z